Recent studies suggest that liver cirrhosis is reversible after administering oral nucleos(t)ide analogue therapy to patients with hepatitis B virus (HBV) infection. However, few studies have addressed whether esophageal varices can regress after such therapy. We report a case of complete regression of esophageal varices during entecavir therapy in patients with HBV-related liver cirrhosis, suggesting that complications of liver cirrhosis such as esophageal varices can regress after the long-term suppression of HBV replication.
All Keywords
【저자키워드】 Hepatitis B virus, Liver cirrhosis, entecavir, Esophageal varices,
【저자키워드】 Hepatitis B virus, Liver cirrhosis, entecavir, Esophageal varices,